Alibaba faces securities fraud probe amid AI distillation fallout

Anthropic has accused Alibaba ↗ 1.28% of running the largest known campaign to extract capabilities from its Claude AI model, an allegation that has wiped roughly a quarter of Alibaba's market value and drawn the attention of securities fraud investigators.

The Allegation

In a letter dated June 10, 2026, sent to Senate Banking Committee chair Tim Scott and ranking member Elizabeth Warren, Anthropic alleged that operators tied to Alibaba's Qwen research lab created approximately 25,000 fraudulent accounts and used them to generate 28.8 million exchanges with Claude between April 22 and June 5, 2026. The company described the effort as "the largest operation to unlawfully extract Claude's capabilities," targeting the model's software engineering, agentic reasoning, and long-horizon task execution functions.reuters+2

Reuters first reported the letter's contents on June 24, with CNBC and the BBC publishing confirmations the same day. Anthropic has not filed a lawsuit, instead taking its case directly to lawmakers — a choice that reflects the unsettled legal status of AI model outputs under existing copyright and trade-secret law.bbc+3

Market Fallout

Alibaba's ADR fell 7.34% over the two trading sessions following the Reuters report, closing at $95.07 on June 25. The stock continued sliding to a 16-month low as investors treated the allegation as a broader risk signal for Chinese tech companies with exposure to US frontier models. Baidu ↗ 3.01% and Xiaomi also fell sharply in the aftermath.prnewswire+1

Southbound capital flows on July 30 showed continued selling pressure, with HK$1.122 billion in net outflows from Alibaba's Hong Kong-listed shares and 69.38 million shares sold off over the prior five trading days. Pomerantz LLP announced on July 30 that it is investigating potential securities fraud claims on behalf of Alibaba investors, citing both the distillation allegation and a separate $600 million non-prosecution agreement with the Department of Justice over illegal pharmaceutical sales on Alibaba's platforms.news.futunn+1

Alibaba's Response and What Comes Next

Alibaba denies wrongdoing and specifically denied Chinese government involvement, but has not issued a detailed rebuttal of the account and exchange figures. On July 6, CNBC reported that the company placed Anthropic's software on a high-risk list and directed employees to uninstall Claude.bbc+1

In Congress, the Deterring American AI Model Theft Act (H.R. 8283) passed the House Foreign Affairs Committee unanimously, and bipartisan legislation in the Senate would authorize sanctions against entities found to have conducted large-scale distillation campaigns. Despite the stock's slide, Wall Street's consensus rating on Alibaba remains a Strong Buy with a median price target near $190 — a gap that reflects how differently analysts and traders are weighing an unproven allegation against the company's underlying business.tech-insider+2